Veterinary Medicine Information website

BIOCAN DHPPi + L PLUS

Authorised
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, Live
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Canine adenovirus 2, Live
  • Canine distemper virus, strain CDVU 39, Live
Download as PDF

Product identification

Medicine name:
BIOCAN DHPPi + L PLUS
Active substance:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, Live
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Canine adenovirus 2, Live
  • Canine distemper virus, strain CDVU 39, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
    32.00
    log2 geometric mean titre
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Canine adenovirus 2, Live
    3.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain CDVU 39, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2899
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/07/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/07/2023
Download